Role of organic cation transporter-1 (OCT-1) in drug resistance condition of ph plus chronic myeloid leukemia (CML)

被引：0
|
作者：
Patel, Saumya [1 ]
Shah, Krupa [2 ]
Rawal, Rakesh [1 ]
机构：
[1] Gujarat Univ, Ahmadabad, Gujarat, India
[2] Gujarat Canc Res Inst, Ahmadabad, Gujarat, India
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-2106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2106
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A PHOTOMETRIC-STUDY OF THE STANDARD PHILADELPHIA (PH1) TRANSLOCATION OF CHRONIC MYELOID-LEUKEMIA (CML)
    WAYNE, AW
    SHARP, JC
    CANCER GENETICS AND CYTOGENETICS, 1982, 5 (03) : 253 - 256
  • [22] Role of fibronectin 1 in tyrosine kinase inhibitor resistance in chronic myeloid leukemia
    Tiedemann, L.
    Pott, C.
    Schmidt, L. S.
    Litterst, M.
    Cascorbi, I.
    Kaehler, M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 : S41 - S41
  • [23] Standardization of Two Dpcr Platforms for Detection of BCR/ABL1-Minimal Residual Disease (MRD) in Ph plus Chronic Myeloid Leukemia (CML)
    Fava, Carmen
    Bernardi, Simona
    Gottardi, Enrico Marco
    Daraio, Filomena
    Giugliano, Emilia
    Lorenzatti, Roberta
    Varotto, Marta
    Barberio, Davide
    Galeotti, Laura
    Ceccherini, Francesco
    Cordoni, Francesco
    Rege-Carmbrin, Giovanna
    Saglio, Giuseppe
    Russo, Domenico
    BLOOD, 2017, 130
  • [24] Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia
    S H Han
    S-H Kim
    H-J Kim
    Y Lee
    S-Y Choi
    G Park
    D-H Kim
    A Lee
    J Kim
    J-M Choi
    Y Kim
    K Myung
    H Kim
    D-W Kim
    Leukemia, 2017, 31 : 1532 - 1539
  • [25] Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia
    Vine, Jacob
    Bar Cohen, Sara
    Ruchlemer, Rosa
    Goldschmidt, Neta
    Levin, Moshe
    Libster, Diana
    Gural, Alexander
    Gatt, Moshe E.
    Lavie, David
    Ben-Yehuda, Dina
    Rund, Deborah
    LEUKEMIA & LYMPHOMA, 2014, 55 (11) : 2525 - 2531
  • [26] Functional Activity of the OCT-1 Protein Is Predictive of Long-Term Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib
    White, Deborah L.
    Dang, Phuong
    Engler, Jane
    Frede, Amity
    Zrim, Stephanie
    Osborn, Michael
    Saunders, Verity A.
    Manley, Paul W.
    Hughes, Timothy P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2761 - 2767
  • [27] PROGNOSTIC VALUE OF CHROMOSOMAL FINDINGS IN THE BLAST PHASE OF PH1-POSITIVE CHRONIC MYELOID-LEUKEMIA (CML)
    OLAH, E
    RAK, K
    INTERNATIONAL JOURNAL OF CANCER, 1981, 27 (03) : 287 - 295
  • [28] A CASE OF PH1 NEGATIVE CHRONIC MYELOID-LEUKEMIA (CML) WITH CHROMOSOME-PULVERIZATION AND HETEROPLOID MITOSES
    SUCIU, S
    MARINCA, E
    PETROV, L
    ARCHIV FUR GESCHWULSTFORSCHUNG, 1982, 52 (08): : 625 - 628
  • [29] A Phase 1/2 Study Of Bosutinib (SKI-606) In Japanese Adults With Philadelphia Chromosome-Positive (Ph plus ) Chronic Myeloid Leukemia (CML)
    Takahashi, Naoto
    Ishizawa, Kenichi
    Nakaseko, Chiaki
    Kobayashi, Yukio
    Ohashi, Kazuteru
    Nakagawa, Yasunori
    Yamamoto, Kazuhito
    Miyamura, Koichi
    Taniwaki, Masafumi
    Okada, Masaya
    Kawaguchi, Tatsuya
    Shibata, Atsushi
    Fujii, Yosuke
    Ono, Chiho
    Ohnishi, Kazunori
    BLOOD, 2013, 122 (21)
  • [30] Classification of Patients With Chronic Myeloid Leukemia on Basis of BCR-ABL Transcript Level at 3 Months Fails to Identify Patients With Low Organic Cation Transporter-1 Activity Destined to Have Poor Imatinib Response
    White, Deborah L.
    Hughes, Timothy P.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (10) : 1144 - 1145
12345